Literature DB >> 9185765

Prevalence of hereditary hemochromatosis in a Massachusetts corporation: is Celtic origin a risk factor?

B N Smith1, W Kantrowitz, N D Grace, M S Greenberg, T J Patton, R Ookubo, K Sorger, J G Semeraro, J R Doyle, A G Cooper, B R Kamat, L M Maregni, W M Rand.   

Abstract

The prevalence of homozygous hereditary hemochromatosis (HHC) is estimated at 1:250 in Caucasian adults. Little is known about ethnic subpopulations that might be at increased risk for this disease. HLA data have suggested a Celtic origin for HHC. Screening for HHC was offered to all employees of the Massachusetts Polaroid Corporation. Participants with a transferrin saturation of >55% or >45% and an elevated serum ferritin concentration on two screenings were referred for liver biopsy. The diagnosis of HHC was based on histological criteria, quantitative hepatic iron determination, hepatic iron index, and the phlebotomy requirement for iron depletion. Participants completed a questionnaire regarding their ethnic background. Two thousand two hundred ninety-four employees were screened, and 5 cases of HHC were detected. All 5 cases involved Caucasian men, yielding a prevalence of 1:395 for the Caucasian population. Four of the 5 cases were of 100% British-Irish ancestry based on the country of origin of their grandparents. Additional analysis revealed that the majority of grandparents of all 4 individuals came from Ireland or Wales. The exact two-tailed trend test showed a significant association of HHC with Celtic background (P = .012). The estimated cost of screening per patient identified was $18,041. Polaroid Corporation has a high representation of employees of British-Irish ancestry. Our data suggest that they are at high risk for developing HHC. A significant association of HHC with Celtic ancestry was found in this subpopulation, supporting the concept of a Celtic origin for this disease.

Entities:  

Mesh:

Year:  1997        PMID: 9185765     DOI: 10.1002/hep.510250622

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  8 in total

1.  The frequency of C282Y and H63D mutations in Hemochromatosis gene in native Estonians.

Authors:  P Pärlist; A V Mikelsaar; G Tasa; L Beckman
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

2.  High frequency of the haemochromatosis C282Y mutation in Hungary could argue against a Celtic origin of the mutation.

Authors:  A Tordai; H Andrikovics; L Kalmár; K Rajczy; M Pénzes; B Sarkadi; I Klein; A Váradi
Journal:  J Med Genet       Date:  1998-10       Impact factor: 6.318

3.  Automated measurement of unsaturated iron binding capacity is an effective screening strategy for C282Y homozygous haemochromatosis.

Authors:  P E Hickman; L F Hourigan; L W Powell; F Cordingley; G Dimeski; B Ormiston; J Shaw; W Ferguson; M Johnson; J Ascough; K McDonell; A Pink; D H Crawford
Journal:  Gut       Date:  2000-03       Impact factor: 23.059

4.  Individuals homozygous for the H63D mutation have significantly elevated iron indexes.

Authors:  Jason Samarasena; Wendy Winsor; Richard Lush; Peter Duggan; Yagang Xie; Mark Borgaonkar
Journal:  Dig Dis Sci       Date:  2006-04       Impact factor: 3.199

5.  The significance of haemochromatosis gene mutations in the general population: implications for screening.

Authors:  M J Burt; P M George; J D Upton; J A Collett; C M Frampton; T M Chapman; T A Walmsley; B A Chapman
Journal:  Gut       Date:  1998-12       Impact factor: 23.059

6.  Screening for hemochromatosis in Turkey.

Authors:  Hakan Bozkaya; Mehmet Bektas; Olga Metin; Ozlem Erkan; Dicle Ibrahimoglu; Klara Dalva; Filiz Akbiyik; Selim Gurel; Abdurrahman Mithat Bozdayi; Cemal Akay; Cihan Yurdaydin; Onder Aslan; Ozden Uzunalimoglu
Journal:  Dig Dis Sci       Date:  2004-03       Impact factor: 3.199

Review 7.  Ethnic Differences in Iron Status.

Authors:  Wanhui Kang; Alexa Barad; Andrew G Clark; Yiqin Wang; Xu Lin; Zhenglong Gu; Kimberly O O'Brien
Journal:  Adv Nutr       Date:  2021-10-01       Impact factor: 8.701

8.  Serum or plasma ferritin concentration as an index of iron deficiency and overload.

Authors:  Maria Nieves Garcia-Casal; Sant-Rayn Pasricha; Ricardo X Martinez; Lucero Lopez-Perez; Juan Pablo Peña-Rosas
Journal:  Cochrane Database Syst Rev       Date:  2021-05-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.